Cell and Gene Therapy (CGT) Quality Program Owner | Cell and Gene Therapy (CGT) Quality Program Owner (m/f/d)

Job Summary

As the CGT Quality Program Owner at Bayer, you will be the primary architect and lead for the global Quality Management System (QMS) specifically tailored for Cell and Gene Therapy. This high-impact role involves designing and implementing core quality programs and standards across the entire Bayer network, spanning from early development to commercial phases. You will act as a critical bridge between manufacturing, supply chain, and regulatory affairs, ensuring all Advanced Therapy Medicinal Products (ATMPs) meet strict GxP and regulatory requirements. Day-to-day, you will provide strategic oversight, facilitate FDA inspection readiness, and lead a matrixed organization of subject matter experts. This position is particularly attractive due to its high level of accountability, the opportunity to shape the quality landscape for cutting-edge medical technologies, and a highly competitive compensation package including hybrid work flexibility and extensive family support benefits.